Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 912,600 | 980,900 | 387,600 | 2,961,600 | 2,412,100 |
| Depreciation Amortization | 354,700 | 229,700 | 112,300 | 638,000 | 398,600 |
| Income taxes - deferred | -377,700 | -170,900 | -64,500 | -168,600 | -139,800 |
| Accounts receivable | -76,500 | 21,800 | 114,800 | -203,400 | -109,500 |
| Other Working Capital | -600 | -315,000 | -184,100 | -890,300 | 97,200 |
| Other Operating Activity | 722,200 | 195,800 | 89,200 | -953,000 | -1,099,300 |
| Operating Cash Flow | $1,534,700 | $942,300 | $455,300 | $1,384,300 | $1,559,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -211,800 | -137,600 | -66,600 | 342,300 | 428,700 |
| Net Acquisitions | -5,547,500 | 788,100 | N/A | N/A | 990,300 |
| Purchase Of Investment | -5,140,700 | -4,120,300 | -1,321,200 | -3,448,500 | -2,805,900 |
| Sale Of Investment | 7,487,000 | 1,785,400 | 440,500 | 4,661,300 | 3,104,700 |
| Purchase Sale Intangibles | -34,400 | -21,000 | -5,000 | -2,900 | -1,900 |
| Other Investing Activity | -35,700 | -22,100 | -5,700 | 21,500 | -100 |
| Investing Cash Flow | $-3,448,700 | $-1,706,500 | $-953,000 | $1,576,600 | $1,717,700 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 997,200 | N/A | N/A | N/A | 0 |
| Debt Repayment | -159,900 | N/A | N/A | -1,002,200 | -1,002,200 |
| Common Stock Issued | N/A | N/A | N/A | N/A | -5,800 |
| Common Stock Repurchased | N/A | N/A | N/A | -750,000 | -750,000 |
| Other Financing Activity | -41,900 | -53,200 | -43,400 | 4,900 | 18,100 |
| Financing Cash Flow | $795,400 | $-53,200 | $-43,400 | $-1,747,300 | $-1,739,900 |
| Exchange Rate Effect | -12,800 | 15,900 | 20,000 | -55,700 | -122,900 |
| Beginning Cash Position | 3,419,300 | 3,419,300 | 3,419,300 | 2,261,400 | 2,261,400 |
| End Cash Position | 2,287,900 | 2,617,800 | 2,898,200 | 3,419,300 | 3,675,600 |
| Net Cash Flow | $-1,131,400 | $-801,500 | $-521,100 | $1,157,900 | $1,414,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,534,700 | 942,300 | 455,300 | 1,384,300 | 1,559,300 |
| Capital Expenditure | -211,800 | -137,600 | -66,600 | -240,300 | -153,900 |
| Free Cash Flow | 1,322,900 | 804,700 | 388,700 | 1,144,000 | 1,405,400 |